跳至主要内容
临床试验/NCT01207869
NCT01207869Unknown1 期

Intratracheal Instillation of Umbilical Cord-derived Mesenchymal Stem Cells as a Rescue Treatment for Severe Bronchopulmonary Dysplasia

China Medical University Hospital2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2010年7月最近更新:
适应症

试验速览

阶段
1 期
入组人数
10
试验地点
2
主要终点
The relations between the cytokine concentrations in the BAL fluid and PAP.

研究概览

简要总结

Mesenchymal stem cells (MSCs) have been reported to be effective to prevent alveolar growth arrest in experimental bronchopulmonary dysplasia (BPD). The aim is to treat the extremely premature infant with severe BPD to establish whether intratracheal instillation of umbilical cord-derived MSCs (ucMSCs) is safe and effective as a rescue treatment for severe BPD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Investigator)

入排标准

年龄范围
1 Week 至 6 Months(Child)
性别
All
接受健康志愿者

入选标准

  • severe BPD, defined by the National Institute of Child Health and Human Development workshop, who conventional therapies (including furosemide and theophylline, and HFO ventilation) has failed

排除标准

  • severe congenital anomalies
  • severe intraventricular hemorrhage ≥ grade 3 or cystic periventricular leukomalacia.

结局指标

主要结局

The relations between the cytokine concentrations in the BAL fluid and PAP.

时间窗: Up to 20 weeks

To examine the relations between the cytokine concentrations in the BAL fluid and PAP.

次要结局

  • The severity score of BPD ranging from 0 to 6 on the serial chest radiographs(6 months to 1 year)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验